FDA advisory panel reviews safety of ultra-processed baby foods

An FDA advisory panel is evaluating the health implications of ultra-processed ingredients in infant nutrition products. The review coincides with broader public health concerns regarding rising measles cases and pharmaceutical developments, though the specific regulatory outcomes remain uncertain.